drugset / Trial / NCT01086969
A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the safety and immunogenicity of a single dose of Menactra® vaccine to support registration. Primary Objectives: * To describe the antibody titers measured by serum bactericidal activity using baby rabbit complement (SBA-BR) before and after Menactra® vaccination. * To describe the safety profile of participants after one dose of Menactra®.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-02
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Menactra | Vaccine | 0.5 ml | Intramuscular |